Endometriosis, one of the most prevalent gynaecological disorders, may affect fertility. Extensive research has been done in an attempt to understand the pathogenesis of endometriosis and its association with reproductive failure. It has been suggested that the disease affects almost any step of reproduction, but data are mostly controversial so it is difficult to draw clear conclusions from studies that have been done so far. Not only is peritoneal fluid in close proximity to endometriotic lesions, but it is also the environment in which early reproductive events take place. Studies on the peritoneal fluid in endometriosis have provided significant data towards an understanding of this disease. Immunological factors play a key role in determining the occurrence of endometriosis as well as its heterogenous symptoms. Since data also indicate that there are immunological differences between infertile and fertile women with endometriosis, recent studies have been designed to take these differences into consideration. This review will discuss the mechanisms by which endometriosis may affect fertility, and an emphasis will be placed on the relevance of the peritoneal fluid.
Introduction
Endometriosis, one of the most prevalent gynaecological disorders, may affect fertility. Although the incidence of infertility is -15% in the general population, the incidence of infertility is 30-40% in patients with endometriosis. It is estimated that 25-50% of infertile women have endometriosis Damario and Rock, 1993) .
Infertility associated with the advanced stages of endometriosis may, at least partly, be explained by the anatomical distortion caused by the disease in the female reproductive tract. However, infertility associated with minimal or mild endometriosis, as well as the negative impact of all stages of the disease on implantation rates after assisted reproductive techniques (Simon et al., 1994; Arici et al., 1996a) , requires the identification of other pathophysiological mechanisms.
The presence of endometriosis (and its stage) do not predict the various symptoms associated with this disorder. Recently, a report (Balasch et al., 1996) showed that there was no difference between asymptomatic infertile and fertile women in the stage (American Fertility Society, 1985) and the appearance of endometriosis. Endometriosis is a heterogeneous disease and the mechanisms by which it may cause reproductive failure appear to be heterogeneous. Substantial evidence suggests that immunological factors are involved in the pathogenesis of endometriosis and in endometriosis-associated reproductive failure.
Peritoneal fluid (PF) has been a focus of research on endometriosis because of the extent of information it potentially carries about the disease. PF, because of its proximity to endometriotic lesions, is the milieu in which the immune mediators associated with the local inflammation of endometriosis can be studied. PF is also the microenvironment in which early reproductive events such as ovulation, ovum retrieval, and sperm-oocyte interaction take place. It may also play a central role in the pathogenesis of the disease through stimulation of endometrial cell proliferation (Arici et al, 1998b) .
This review discusses the mechanisms by which endometriosis may impair fertility, emphasizing the relevance of the peritoneal fluid.
Role of peritoneal fluid in the pathogenesis of endometriosis Endometriosis is defined histologically as the presence of endometrial glands and stroma outside the uterine cavity. Today's understanding of the aetiology of the disease is based on Sampson's hypothesis that the implantation of endometrial cells in the peritoneum is a result of retrograde menstruation (Sampson, 1927) , although additional mechanisms are involved. It has been shown that the reflux of endometrial tissue during menstruation is not restricted to women with endometriosis since it also occurs in normally cycling women (Halme et al., 1984b; Kruitwagen et al, 1991) . One possible explanation of why endometriosis develops in some women and not in others is that the peritoneal environment in women with endometriosis may be different from that in women without endometriosis so that the implantation and growth of endometrial cells is encouraged.
Several studies have used endometrial stromal and glandular cell cultures as a model for endometriosis in order to test the hypothesis that PF is growth-stimulatory in endometriosis. Surrey and Halme were able to detect a significant proliferative effect of the cell-free fraction of the PF from women with endometriosis on endometrial stromal cells ). Other workers (Koutsilieris et al, 1991; Overton et al, 1997) subsequently investigated whether there was a similar effect on endometrial epithelial and stromal cells of rabbits and humans respectively, but they could not confirm the presence of an additional mitogenic factor in the PF of women with endometriosis. However, both investigators did show that there was a dose-dependent proliferative effect of PF from women with or without endometriosis on these cells in vitro. We have recently shown that interleukin (IL)-8, a neutrophil chemotactic and activating cytokine with potent angiogenic activity, is constitutively produced in the normal endometrium and induces the proliferation of endometrial stromal cells in vitro (Arici et al, 1998a,b) . Increased concentrations of IL-8 are found in the PF of women with endometriosis (Ryan et al, 1995; Arici et al., 1996c) . Together, these data suggest an important role for IL-8 in the pathogenesis of endometriosis. However, during the interpretation of these data, we should keep in mind that the results may not reflect events in vivo, since isolated cells may lose their ability to respond to stimuli that they possessed as whole tissue.
It is known that the progression of endometriotic lesions is influenced by ovarian endocrine function. Endometriosis is restricted to women of reproductive age, and surgical or medical stertilization is an effective treatment for women with the disease who do not seek fertility. The steroid responsiveness of endometriotic implants has been shown by several studies, and both oestrogen and progesterone receptors are present in the lesions (Bergqvist et al., 1985; Lessey et al., 1989) . However, no significant differences in the PF oestradiol concentrations between women with and without endometriosis have been found Overton et al., 1997) . Also, there is no evidence that there is any correlation between the oestrogen concentrations in the PF and in-vitro proliferation of endometrial cells isolated from women either with or without endometriosis (DeLeon, et al., 1986; Overton et al, 1997) .
Most steroid hormone actions on the endometrium are not direct, but are mediated by paracrine factors such as cytokines and growth factors. Oestradiol has been shown to have a rapid stimulatory effect on vascular endothelial growth factor (VEGF) mRNA and on protein synthesis in endometrial stromal cells (Shifren et al, 1996) . VEGF is a potent angiogenic factor and, as its concentrations are elevated in the PF of women with endometriosis, it is possible that VEGF may play a role in the pathogenesis of this disease (McLaren et al, 1996a; Taylor et al, 1997) . Likewise, the secretion of IL-6 (a monocyte/macrophage differentiation activator) is stimulated by oestradiol in endometrial stromal cells in culture (Taylor et al, 1997) . Although IL-6 was reported to inhibit endometrial stromal cell proliferation (Tabibzadeh etal, 1989; Zarmakoupise?a/., 1995) , resistance of ectopic endometrial stromal cells to IL-6-mediated growth inhibition has also been suggested .
Endometriotic implants are frequently accompanied by neovascularization, which may be critical for the progression of the lesions. Oosterlynck et al, using the chick chorioallantoic membrane bioassay (Oosterlynck et al, 1993) , and recently Taylor et al., using an in-vitro model of endothelial cell proliferation (Taylor et al., 1997) , were able to demonstrate that the PF from women with endometriosis show greater angiogenic activity than the PF from women without the disease. Potential candidates for this angiogenic activity in the PF are VEGF and IL-8. Both VEGF and IL-8 concentrations are elevated in the PF of women with endometriosis, and are also correlated with the stage of the disease (Ryan et al., 1995; Arici et al, 1996b; McLaren et al, 1996a; Taylor et al, 1997) . However, another recently published study found that the PF concentrations of IL-8 were higher in early stages of endometriosis, supporting the theory that IL-8 contributes to the pathogenesis of endometriosis by promoting neovascularization (Gazvani et al, 1998) . There are multiple cellular sources that may account for the increased concentrations of VEGF and IL-8 in the PF. Activated macrophages produce both VEGF and IL-8 (Koch et al, 1992; McLaren et al, 1996b) and, since data show that activated macrophages accumulate in both the PF of women with endometriosis (Haney et al, 1981) and in endometriotic implants (Klein et al, 1993; Jones et al, 1996) , these cells may be the primary source of these cytokines. Both substances are also produced by the normal endometrium (Shifren et al, 1996; Arici et al, 1998b) . Thus, it is also possible that the elevated PF concentrations are produced by the endometriotic implants. Recently, it was demonstrated that activated peritoneal macrophages were the principal source of VEGF in endometriosis (McLaren et al, 1996b) . These authors also showed that PF macrophages were directly stimulated by ovarian steroids to secrete VEGF. We have shown that endometrium, mesothelial cells, ovarian stromal and granulosa-lutein cells produce IL-8 (Arici etal, 1996b (Arici etal, ,c, 1998b . The principal source(s) of IL-8 in the PF in endometriosis is, as yet, undetermined.
The oxidant/antioxidant imbalance in the PF of women with endometriosis was the subject of recent investigations (Ho et al, 1997) . These authors found no significant differences in the PF concentration of nitric oxide metabolism products and total antioxidant status between women with early or advanced stage endometriosis and controls. Similarly, inhibin A and B, and activin A concentrations in the PF were not significantly different between healthy women and patients with endometriosis (Florio et al, 1998) .
Effect of endometriosis on reproductive events
Folliculogenesis and ovulation Anovulation, i.e. failure to extrude an ovum with subsequent luteinization of the unruptured follicle (LUF), and luteal phase defect (LPD) are among the ovulatory defects that may exist in women with endometriosis.
The control of ovarian function involves complex interactions between the different cellular components in the ovary, and the cells of the immune system act as important modulators (Adashi, 1989) . Macrophages are not only resident in the ovary but also invade the ovary variably during the ovarian cycle, and they are thought to be are implicated important modulators of ovulation and luteal function (Adashi, 1990a; Hume et al, 1984) .
A local inflammatory reaction involving macrophage activation exists in the pelvic cavity in women with endometriosis, and this inflammation may influence follicular physiology. The number of monocytes/macrophages is higher in the follicular fluid (FF) from women with endometriosis than in the FF of women with tubal factor or idiopathic infertility (Lachapelle et al, 1996) , but it is not known whether these macrophages are also more activated.
Shakil and Whitehead showed that progesterone secretion was inhibited when peritoneal macrophages were co-cultured with rat granulosa cells (Shakil and Whitehead, 1994) . The degree of this inhibition was related to both the number and activation of macrophages. Macrophages secrete IL-1 and tumour necrosis factor-a (TNF-a) and both cytokines inhibit gonadotrophin-induced pro-gesterone production by granulosa cells, as well as androgen production by thecal cells (Kasson and Gorospe, 1989; Roby and Terranova, 1990; Adashi et al, 1990b; Andreani et al, 1991; Hurwitz et al, 1991) . It is difficult to conclude whether cytokines that are secreted by peritoneal macrophages are inhibitors of steroidogenesis, since the opposite has also been reported (Zolti et al, 1990; Brannstrom et al, 1993; Shakil and Whitehead, 1994) . PF from women with endometriosis has been found to stimulate progesterone release from cultured human granulosa-lutein cells and to potentiate the action of human chorionic gonadotrophin (HCG), when compared with controls (Whitehead et al., 1996) . Recently, a significantly lower aromatase activity and progesterone production in pre-ovulatory granulosa cells from infertile women with untreated minimal or mild endometriosis has also been reported (Harlow et al., 1996) . This result suggests a primary dysfunction of steroidogenesis in endometriosis.
Clinical studies investigating whether there is any impairment of follicular development, ovulation, or progesterone secretion in endometriosis are also inconclusive. Studies that used transvaginal ultrasonography to assess LUF in minimal and mild endometriosis reached contradictory results (Mahmood and Templeton, 1991; Mioetal, 1992) . Two studies that compared infertile women with and without endometriosis through endometrial biopsies and peripheral hormonal measurements failed to detect a difference between the luteal phase of the two groups (Kusuhura, 1992; Matorras et al., 1996) . Inherent inaccuracy in the diagnosis of LUF and LPD by transvaginal ultrasonography and endometrial biopsy respectively, may contribute to conflicting results.
It is not known whether FF that contributes to PF plays an important role in the pathogenesis of endometriosis. We have recently demonstrated that several cytokines [monocyte chemoattractant protein-1 (MCP-1), IL-8 and growth-regulated a (Grooc)] that are elevated in the PF of patients with endometriosis are also found in the FF (Arici et al., 1996b (Arici et al., ,c, 1997a Oral et al, 1996b Oral et al, , 1997 . The concentrations of MCP-1 in the FF increase with advancing stages of endometriosis (unpublished observations). The finding that FF from women with endometriosis induces more proliferation of endometrial cells than the FF from women without endometriosis also suggests that cytokines and growth factors of the FF may play a role in the pathogenesis of endometriosis (Bahtiyar et al., 1998) .
Oocyte function
Contrary to earlier reports suggesting a functional defect in the oocytes of endometriosis patients (Wardle et al., 1985 (Wardle et al., , 1986 , more recent studies have found that endometriosis has no effect on oocyte quality, fertilization, and pregnancy rates in patients undergoing assisted reproduction (Braeckmans et al., 1987; Simon et al., 1994; Arici et al., 1996a) . The hypothesis that PF does not affect the oocyte quality and fertilization in vivo is based on the fact that the success rate with gamete intra-Fallopian transfer (GIFT) is equally good in patients with endometriosis, mild peritoneal adhesions, and unexplained infertility. This hypothesis may not be totally correct since, in GIFT, an artificial situation exists where the PF is diluted and the ovum is surrounded by 200 000-500 000 motile spermatozoa. Minguez et al. suggested a defect at the level of oocyte activation as a possible mechanism for the implantation failure associated with endometriosis in couples treated by intracytoplasmic sperm injection (ICSI) (Minguez et al, 1997) .
Sperm function and fertilization
There is no physical barrier between the lumen of the Fallopian tube and the peritoneal cavity. Thus, it is likely that peritoneal fluid admixes with tubal secretions and may potentially affect the gametes and fertilization. Peritoneal macrophages have access to the reproductive tract through the oviducts, and macrophage populations were found to be elevated in the ampullary segment of the Fallopian tube in women with endometriosis (Haney et al, 1991) .
Muscato et al. reported that peritoneal macrophages phagocytosed spermatozoa in vitro and that this activity was higher in women with endometriosis than in women without the disease (Muscato et al, 1982) . Enhanced intratubal phagocytosis of spermatozoa in endometriosis has also been reported (Haney et al, 1981) . In a recent study (Martinez-Roman et al, 1997) , macrophages from infertile women with endometriosis phagocytosed more spermatozoa than did those from fertile women with the disease. However, these findings could not be confirmed by other studies (Halme et al, 1984a; Latif et al, 1989) . In conclusion, the question of whether enhanced phagocytosis of spermatozoa plays a role in endometriosis-associated infertility remains controversial.
Various sperm functions are crucial for successful fertilization, such as the development of hyperactivated motility, the capacity to undergo acrosome reaction and the tight binding of spermatozoa to the zona pellucida. These parameters have been investigated in relation to endometriosis. No difference was found in the recovery of motile spermatozoa from the peritoneal cavity of women with or without endometriosis who underwent laparoscopy immediately after artificial insemination (Stone and Himsl, 1986) . Several studies with different methodologies (use of heat-treated versus non-heat-treated, centrifuged versus filtered PF) revealed a decrease in several sperm motility parameters (Curtis et al, 1993; Aeby et al, 1996) . On the other hand, in a small study (n = 8) which used untreated pooled PFs and a straw swim-up technique (Bielfeld et al, 1993) , and a larger study (Halme and Hall, 1982) which used centrifuged, heat-treated fluids, both groups failed to find any difference in sperm motility. A decrease was recently reported in sperm motility and velocity induced by the PF from moderate or severe endometriosis but not by the PF of minimal and mild endometriosis .
There is also a decreased sperm binding to the zona pellucida in the presence of PF from women with endometriosis that correlates with the severity of the disease (Coddington et al, 1992) . In a recent study (Oehninger et al, 1995) , placental protein 14 (PP14), which is an endometrial epithelial protein, was shown to impair sperm tight binding without affecting other sperm functions. The authors suggested a role for PP14 in endometriosisrelated infertility since PP14 concentrations in the PF are elevated in endometriosis (Koninckx et al, 1992) .
There are only a few studies investigating the effect of PF on the acrosome reaction (Bielfeld et al, 1993; Arumugam, 1994; Tasdemir et al, 1995) . PF from infertile women with endometriosis decreased the acrosome reaction (Tasdemir et al, 1995) . A higher iron concentration in the PF in endometriosis patients was claimed to be responsible for the negative effect on the acrosome reaction (Arumugam, 1994) . One study that did not demonstrate an adverse effect of PF on the acrosome reaction or on sperm membrane integrity and motility involved a small number of patients with endometriosis, so the value of the study is limited (Bielfeld et al, 1993) .
Spermatozoa mixed with PF from women with endometriosis penetrated fewer zona-free hamster eggs than did spermatozoa that were mixed with PF from controls (Chacho et al, 1986) . In a recent well-designed study, cell-free fraction and nonheat-inactivated PF from women with minimal endometriosis impaired zona-free hamster egg penetration (Aeby et al, 1996) . On the other hand, Halme and Hall used heat-treated PF from women with or without endometriosis and found no difference in the zona-free hamster egg penetration (Halme and Hall, 1982) . These contradictory findings may be due to the differences in methodology.
In conclusion, data on the effect of endometriosis on sperm function and fertilization is controversial, and differences in methodology such as the use of the cellular or the non-cellular fraction and the use of heat-labile or the non-heat-labile fraction of the PF might contribute to the conflicting results. It is also not clear if any proposed dysfunction is related to the severity of endometriosis. Future studies that compare infertile women with endometriosis to fertile women with the disorder would be ideal to assess the significance of these findings. Importantly, studies focusing on whether the observed effects are reversed by medical or surgical treatment of minimal to mild endometriosis may help in early referral of patients who would benefit from assisted reproduction techniques.
Tubal transport
The presence of a factor in the PF of women with endometriosis that causes inhibition of ovum capture by decreasing tubal fimbria action was reported (Suginami et al, 1986 ). The substance was described as being water-soluble, and its concentrations are decreased with Danazol treatment.
Several investigators who have analysed the prostaglandin content of PF from patients with endometriosis as well as from healthy controls revealed controversial results (Chacho et al, 1986; Dawood et al, 1984; DeLeon et al, 1986; Karck et al., 1996) . The production of prostaglandin E and prostaglandin F from the isthmic and ampullary portions of the Fallopian tube is higher in women with endometriosis compared with healthy controls (Nabekura et al., 1994) . No negative effect of PF from superovulated patients with endometriosis on oviduct transport was found in a murine model (Dodds et al., 1992) . In conclusion, whether altered tubal or uterine contractility affects fertility in endometriosis is unknown.
Embryo development
Embryotoxic factors, the nature of which is yet unknown, have been reported to be present in women with endometriosis as well as in women with unexplained infertility and recurrent pregnancy loss (Oksenberg and Brautbar, 1986; Damewood et al, 1990; Hill et al, 1992) . Embryotoxic activity, by affecting pre-implantation, peri-implantation, or embryonic development may have an impact on pregnancy achievement or loss.
Several studies using the murine model revealed that sera from women with endometriosis were inhibitory to in-vitro fertilization (IVF) and early embryo development (Damewood et al, 1990; Abu-Musa et al, 1992a,b; Miller et al, 1995; Ito et al, 1996; Martinez-Roman et al, 1997) . Invitro incubation of mouse embryos in the PF from women with endometriosis was also reported to impair the development of 2-cell mouse embryos (Marcos et al, 1985; Prough et al, 1990) . This effect was more pronounced when the PF from infertile women with endometriosis was used than when the PF of fertile women with endometriosis was used (Martinez-Roman et al, 1997) . These findings were confirmed in in-vivo murine studies (Steinleitner et al, 1990a,b) , where i.p. injection of PF from women with endometriosis and activated mice macrophages showed decreased oocyte recovery and embryo development. Other studies failed to find a similar effect (Awadalla et al, 1987; Dodds et al, 1992) .
It is not known whether human and mouse embryos are susceptible to the same toxic factors, and the murine model may be criticised for the invivo assessment of embryo toxicity since there is a bursa connecting the distal tube to the ovary which may block the transfer of i.p. fluids in the mouse. Studies that include data on humans reveal that subjects with endometriosis show increased aberrant nuclear and cytoplasmic events in embryos, decreased embryo cleavage rates, an increased percentage of arrested development, and a significant decrease in the number of blastomeres (Brizek et al, 1995; Pellicer et al, 1995; Tanbo et al, 1995) . The study in which' women with endometriosis who received donated oocytes due to low response in previous IVF cycles (Remohi et al, 1997) , demonstrated a similar pregnancy rate compared with those in patients in other diagnostic groups and raises the possibility that embryo toxicity is a clinically relevant cause in endometriosis-related infertility. The culprit, whether it is a factor present in the PF or not, awaits to be identified through studies on human embryos.
Implantation
Implantation involves complex interactions between embryonic and uterine cells, and in this process a receptive state of the uterus is required. Several studies reported lower implantation rates with assisted reproduction in women with endometriosis (Yovich et al, 1988; Simon et al, 1994; Arici et al, 1996a) . Besides the embryotoxic environment, intrinsic endometrial defects may account for the implantation failure in women with endometriosis. In the assessment of uterine receptivity, research has focused on integrins. The aberrant expression of a v (33 integrin, a marker of the window of implantation, was reported in women with minimal or mild endometriosis (Lessey et al, 1994) . This finding was not confirmed in subsequent studies (Bridges et al, 1994; Hii and Rogers, 1998) .
Conclusion
Although conflicting data exists, the extensive research on endometriosis seems to lead to the conclusion that endometriosis is primarily an immunological disorder and that infertile women with endometriosis are distinct from women with endometriosis who are fertile. In order to identify factors that compare infertile and fertile women with endometriosis are needed. It is likely that there may be more than one defect involved and that a spectrum of any of these defects may operate to result in impaired reproduction. Since the PF is potentially involved in any step resulting in infertility, it will continue to be a major area of research for endometriosis-related infertility.
